{"id":{"repo_id":"duquesne","oai_identifier":"oai:dsc.duq.edu:etd-3229"},"canonical_url":"https://search.ndltd.org/etd/duquesne/oai:dsc.duq.edu:etd-3229","repository":{"repo_id":"duquesne","name":"Duquesne","base_url":"https://dsc.duq.edu/do/oai/"},"display":{"title":"SYSTEMATIC PRODUCT AND PROCESS DESIGN OF VERSATILE PERFLUOROCARBON NANOEMULSIONS FOR ELIMINATION OF HYPOXIA AND REACTIVE OXYGEN SPECIES","abstract":"According to a 2022 report, organs destined for transplantation are discarded 15% of the time for various reasons (Israni et al. 2022). This highlights a critical need in transplant practices. Transplant donor tissues are in need of essential nutrients, including molecular oxygen, to maintain integrity during preservation. A current trend in preservation is to perfuse the ex vivo tissue graft with nutrient-rich aqueous perfusate on a closed circuit. This practice, known as machine perfusion (MP) is limited by the absence of an oxygen-carrying component in the perfusate. Additionally, injuries to the recipient are sustained on reperfusion of the transplanted graft. Reactive oxygen species (ROS) are produced during ischemia-reperfusion (IR) events such as transplantation and contribute to secondary oxidative damage. Perfluorocarbon (PFC) materials, which are characteristically good oxygen carriers, can be utilized to fulfill the role of oxygen carrier. PFCs are hydrophobic and must therefore be formulated as a liquid dispersion (e.g., PFC-in-water nanoemulsion (NE)) in order to be considered as a biomedical-grade product. Stability difficulties is one reason why PFC-NEs have not acquired commercial success. We believe that utilization of systematic Quality by Design (QbD) principles may hold the key to overcoming poor stability and generating a stable, proficient oxygen carrier. The central hypothesis of this work is that QbD-centered development can yield colloidally stable antioxidant- and molecular-oxygen-co-loaded PFC-NEs for action against oxidative stress and hypoxia in ex vivo machine perfusion preservation. We test this hypothesis by adapting QbD concepts to the development of PFC-NEs. We used quality risk management and multivariate statistical modeling to deepen the understanding of the process and composition of PFC-NEs. We proposed an optimal formulation and demonstrated its process robustness. Finally, we illustrate its impact in scavenging radical species and delivering oxygen intracellularly in macrophages.","abstract_html":"According to a 2022 report, organs destined for transplantation are discarded 15% of the time for various reasons (Israni et al. 2022). This highlights a critical need in transplant practices. Transplant donor tissues are in need of essential nutrients, including molecular oxygen, to maintain integrity during preservation. A current trend in preservation is to perfuse the ex vivo tissue graft with nutrient-rich aqueous perfusate on a closed circuit. This practice, known as machine perfusion (MP) is limited by the absence of an oxygen-carrying component in the perfusate. Additionally, injuries to the recipient are sustained on reperfusion of the transplanted graft. Reactive oxygen species (ROS) are produced during ischemia-reperfusion (IR) events such as transplantation and contribute to secondary oxidative damage. Perfluorocarbon (PFC) materials, which are characteristically good oxygen carriers, can be utilized to fulfill the role of oxygen carrier. PFCs are hydrophobic and must therefore be formulated as a liquid dispersion (e.g., PFC-in-water nanoemulsion (NE)) in order to be considered as a biomedical-grade product. Stability difficulties is one reason why PFC-NEs have not acquired commercial success. We believe that utilization of systematic Quality by Design (QbD) principles may hold the key to overcoming poor stability and generating a stable, proficient oxygen carrier. The central hypothesis of this work is that QbD-centered development can yield colloidally stable antioxidant- and molecular-oxygen-co-loaded PFC-NEs for action against oxidative stress and hypoxia in ex vivo machine perfusion preservation. We test this hypothesis by adapting QbD concepts to the development of PFC-NEs. We used quality risk management and multivariate statistical modeling to deepen the understanding of the process and composition of PFC-NEs. We proposed an optimal formulation and demonstrated its process robustness. Finally, we illustrate its impact in scavenging radical species and delivering oxygen intracellularly in macrophages.","abstract_has_math":false,"creators":["Lambert, Eric"],"institution":null,"degree_name":"PhD","degree_level":"One-year Embargo","degree_discipline":"Pharmaceutics","degree_department":null,"school":null,"contributors":["Jelena M. Janjic","James K. Drennen III","Peter Wildfong","Kevin Tidgewell","Vijay S. Gorantla"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":null,"date_issued":"","date_published":null,"updated_at":"2026-11-19T07:52:32Z","subjects":["nanoemulsions","formulation development","perfluorocarbons","quality by design","ischemia-reperfusion","process validation","artificial oxygen carriers","resveratrol","microfluidization","Pharmaceutics and Drug Design"],"languages":["English"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[]},"links":{"outbound_url":"https://dsc.duq.edu/etd/2260","outbound_label":"Repository record","outbound_source":"dc:identifier","record_url":"https://dsc.duq.edu/etd/2260","record_label":"Repository record","record_kind":"record","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://dsc.duq.edu/do/oai/?verb=GetRecord&metadataPrefix=oai_etdms&identifier=oai%3Adsc.duq.edu%3Aetd-3229","prefix":"oai_etdms"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Jelena M. Janjic","James K. Drennen III","Peter Wildfong","Kevin Tidgewell","Vijay S. Gorantla"]},{"key":"dc:creator","label":"Author","values":["Lambert, Eric"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.available","label":"Dc Date Available","values":["2024-08-30T07:00:00Z"]},{"key":"dc:date.created","label":"Dc Date Created","values":["2023-08-05T07:00:00Z"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Pharmaceutics"]},{"key":"thesis:degree_level","label":"Degree Level","values":["One-year Embargo"]},{"key":"thesis:degree_name","label":"Degree Name","values":["PhD"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["nanoemulsions","formulation development","perfluorocarbons","quality by design","ischemia-reperfusion","process validation","artificial oxygen carriers","resveratrol","microfluidization","Pharmaceutics and Drug Design"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["English"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["https://dsc.duq.edu/etd/2260"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["According to a 2022 report, organs destined for transplantation are discarded 15% of the time for various reasons (Israni et al. 2022). This highlights a critical need in transplant practices. Transplant donor tissues are in need of essential nutrients, including molecular oxygen, to maintain integrity during preservation. A current trend in preservation is to perfuse the ex vivo tissue graft with nutrient-rich aqueous perfusate on a closed circuit. This practice, known as machine perfusion (MP) is limited by the absence of an oxygen-carrying component in the perfusate. Additionally, injuries to the recipient are sustained on reperfusion of the transplanted graft. Reactive oxygen species (ROS) are produced during ischemia-reperfusion (IR) events such as transplantation and contribute to secondary oxidative damage. Perfluorocarbon (PFC) materials, which are characteristically good oxygen carriers, can be utilized to fulfill the role of oxygen carrier. PFCs are hydrophobic and must therefore be formulated as a liquid dispersion (e.g., PFC-in-water nanoemulsion (NE)) in order to be considered as a biomedical-grade product. Stability difficulties is one reason why PFC-NEs have not acquired commercial success. We believe that utilization of systematic Quality by Design (QbD) principles may hold the key to overcoming poor stability and generating a stable, proficient oxygen carrier. The central hypothesis of this work is that QbD-centered development can yield colloidally stable antioxidant- and molecular-oxygen-co-loaded PFC-NEs for action against oxidative stress and hypoxia in ex vivo machine perfusion preservation. We test this hypothesis by adapting QbD concepts to the development of PFC-NEs. We used quality risk management and multivariate statistical modeling to deepen the understanding of the process and composition of PFC-NEs. We proposed an optimal formulation and demonstrated its process robustness. Finally, we illustrate its impact in scavenging radical species and delivering oxygen intracellularly in macrophages."]},{"key":"dc:title","label":"Title","values":["SYSTEMATIC PRODUCT AND PROCESS DESIGN OF VERSATILE PERFLUOROCARBON NANOEMULSIONS FOR ELIMINATION OF HYPOXIA AND REACTIVE OXYGEN SPECIES"]}]}],"canonical_facts":{"dc:contributor":["Jelena M. Janjic","James K. Drennen III","Peter Wildfong","Kevin Tidgewell","Vijay S. Gorantla"],"dc:creator":["Lambert, Eric"],"dc:date.available":["2024-08-30T07:00:00Z"],"dc:date.created":["2023-08-05T07:00:00Z"],"dc:description.abstract":["According to a 2022 report, organs destined for transplantation are discarded 15% of the time for various reasons (Israni et al. 2022). This highlights a critical need in transplant practices. Transplant donor tissues are in need of essential nutrients, including molecular oxygen, to maintain integrity during preservation. A current trend in preservation is to perfuse the ex vivo tissue graft with nutrient-rich aqueous perfusate on a closed circuit. This practice, known as machine perfusion (MP) is limited by the absence of an oxygen-carrying component in the perfusate. Additionally, injuries to the recipient are sustained on reperfusion of the transplanted graft. Reactive oxygen species (ROS) are produced during ischemia-reperfusion (IR) events such as transplantation and contribute to secondary oxidative damage. Perfluorocarbon (PFC) materials, which are characteristically good oxygen carriers, can be utilized to fulfill the role of oxygen carrier. PFCs are hydrophobic and must therefore be formulated as a liquid dispersion (e.g., PFC-in-water nanoemulsion (NE)) in order to be considered as a biomedical-grade product. Stability difficulties is one reason why PFC-NEs have not acquired commercial success. We believe that utilization of systematic Quality by Design (QbD) principles may hold the key to overcoming poor stability and generating a stable, proficient oxygen carrier. The central hypothesis of this work is that QbD-centered development can yield colloidally stable antioxidant- and molecular-oxygen-co-loaded PFC-NEs for action against oxidative stress and hypoxia in ex vivo machine perfusion preservation. We test this hypothesis by adapting QbD concepts to the development of PFC-NEs. We used quality risk management and multivariate statistical modeling to deepen the understanding of the process and composition of PFC-NEs. We proposed an optimal formulation and demonstrated its process robustness. Finally, we illustrate its impact in scavenging radical species and delivering oxygen intracellularly in macrophages."],"dc:identifier":["https://dsc.duq.edu/etd/2260"],"dc:language":["English"],"dc:subject":["nanoemulsions","formulation development","perfluorocarbons","quality by design","ischemia-reperfusion","process validation","artificial oxygen carriers","resveratrol","microfluidization","Pharmaceutics and Drug Design"],"dc:title":["SYSTEMATIC PRODUCT AND PROCESS DESIGN OF VERSATILE PERFLUOROCARBON NANOEMULSIONS FOR ELIMINATION OF HYPOXIA AND REACTIVE OXYGEN SPECIES"],"thesis:degree_discipline":["Pharmaceutics"],"thesis:degree_level":["One-year Embargo"],"thesis:degree_name":["PhD"]},"updated_at":"2026-11-19T07:52:32Z"}